Doseloop Beta

Nifedipine

medication Under review

A calcium channel blocker used to treat high blood pressure and angina.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence on nifedipine in healthy human subjects is limited to pharmacokinetic and pharmacodynamic studies, which consistently show rapid absorption, dose-dependent cardiovascular effects like brief heart rate increases and blood pressure reductions, and good tolerability. No studies demonstrate benefits for longevity, performance, or other supplement-like applications in healthy adults; research focuses on drug kinetics rather than therapeutic gains. Bioequivalence trials confirm consistent safety profiles across formulations, with minor adverse effects like dizziness and headache occurring transiently. Overall consensus supports its pharmacological reliability but does not position it as a supplement for healthy individuals.

Reported Benefits

Reported Side Effects

Research (3 studies)

RCT

Pharmacokinetics of Nifedipine-Sustained Release Tablets in Healthy Subjects After a Single Oral Administration: Bioequivalence Analysis and Food Effects.

Preprint • 2022 • n=94

Sumei Xu, Pingsheng Xu

RCT

Nifedipine: a potent inhibitor of contractions in the body of the human esophagus. Studies in healthy volunteers and patients with the nutcracker esophagus.

Gastroenterology • 1985 • n=8

Not specified in abstract

RCT

Nifedipine: kinetics and dynamics in healthy subjects.

Clinical Pharmacology & Therapeutics • 1984 • n=6

Not specified in abstract

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 1
Side effects noted 2